Ryhan is a Junior Officer for Industry Partnerships & Commercialisation at Imperial’s Faculty of Natural Sciences. He holds an MChem degree in Chemistry w/. Medicinal Chemistry from Newcastle University and a Postgraduate Certificate in Intellectual Property from...
A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.
These novel compounds could be used in the treatment of antibiotic resistant bacterial infections and demonstrate that inhibitors of NorA efflux can prevent the emergence of further resistant strains.
Efficient and localised suppression of wild pest populations
An immunotherapy platform capable of enhancing the anti-tumour efficacy of invariant natural killer T cells (iNKT).
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean nec venenatis arcu. In fermentum non tellus nec vulputate. Integer accumsan, nunc sit amet porta commodo, diam sapien feugiat purus, at imperdiet arcu nisi quis dui. Etiam vel nisl sem. Proin felis nisl, fringilla eu eros ac, sodales pellentesque sem.